The full extent of today's news for Crestor (AZN) won't be known until Nov. 15, when full...
The full extent of today's news for Crestor (AZN) won't be known until Nov. 15, when full "Saturn" results are released. RBS notes AZN set a high-bar 0.65% PAV differential between Crestor and Lipitor (PFE) to demonstrate "statistical significance," but a 0.5% difference might be enough to impress cardiologists.
From other sites
at Zacks.com (Mar 20, 2015)
at Zacks.com (Mar 19, 2015)
at Zacks.com (Mar 18, 2015)
at Nasdaq.com (Feb 17, 2015)
at Benzinga.com (Feb 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs